Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma
Madeline N. Hayes(Oregon Health & Science University), David M. Langenau(Massachusetts General Hospital), Sivasish Sindiri(National Institutes of Health), Jean‐Paul Borg(Centre National de la Recherche Scientifique), Sowmya Iyer(Massachusetts General Hospital), G. Petur Nielsen(Harvard University), Javed Khan(Kent State University), Matt van de Rijn(Stanford University), Mariana L. Oliveira(University of Lisbon), Myron S. Ignatius(The University of Texas at San Antonio Health Science Center), Karin M. McCarthy(Harvard University), Alexander Jin(Massachusetts General Hospital), Berkley E. Gryder(University School), Sara P. Garcia(Hospital San Pedro), David Malkin(University of Toronto), Zainab Motala(University of Toronto)
Cited by 80
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status
|American Journal Of Pathology|2004|662